Alterations in Bile Acid Metabolism Associated With Inflammatory Bowel Disease
- 5 January 2021
- journal article
- review article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 27 (9) , 1525-1540
Abstract
Inflammatory bowel disease (IBD) is a chronic relapsing inflammatory disorder closely related to gut dysbiosis, which is associated with alterations in an important bacterial metabolite, bile acids (BAs). Although certain findings pertinent to BA changes in IBD vary among studies owing to the differences in sample type, quantitated BA species, study methodology, and patient characteristics, a specific trend concerning variations of BAs in IBD has been identified. In elaborating on this observation, it was noted that primary BAs and conjugated BAs are augmented in fecal samples but there is a reduction in secondary BAs in fecal samples. It is not entirely clear why patients with IBD manifest these changes and what role these changes play in the onset and development of IBD. Previous studies have shown that IBD-associated BA changes may be caused by alterations in BA absorption, synthesis, and bacterial modification. The complex relationship between bacteria and BAs may provide additional and deeper insight into host-gut microbiota interactions in the pathogenesis of IBD. The characteristic BA changes may generate profound effects in patients with IBD by shaping the gut microbiota community, affecting inflammatory processes, causing BA malabsorption associated with diarrhea, and even leading to intestinal dysplasia and cancer. Thus, therapeutic strategies correcting the alterations in the composition of BAs, including the elimination of excess BAs and the supplementation of deficient BAs, may prove promising in IBD.Keywords
This publication has 103 references indexed in Scilit:
- Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10−/− miceNature, 2012
- Dysbiosis modulates capacity for bile acid modification in the gut microbiomes of patients with inflammatory bowel disease: a mechanism and marker of disease?: Figure 1Gut, 2012
- Crohn disease–associated adherent-invasive E. coli bacteria target mouse and human Peyer’s patches via long polar fimbriaeJournal of Clinical Investigation, 2011
- Inflammatory Bowel DiseaseNew England Journal of Medicine, 2009
- Bile acids: regulation of synthesisJournal of Lipid Research, 2009
- Metabolomics Reveals Metabolic Biomarkers of Crohn's DiseasePLOS ONE, 2009
- Lithocholic acid down-regulation of NF-κB activity through vitamin D receptor in colonic cancer cellsThe Journal of Steroid Biochemistry and Molecular Biology, 2008
- Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseasesProceedings of the National Academy of Sciences, 2007
- The Enzymes, Regulation, and Genetics of Bile Acid SynthesisAnnual Review of Biochemistry, 2003
- Biliary lipid composition in patients with nonoperated Crohn's diseaseDigestive Diseases and Sciences, 1986